ABBV Abbvie Inc
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
$106.70 +1.05 (0.99%)
As of 03/05/2021 16:02:50 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Large cap
Health Care
Drug Manufacturers—General
USA
USA
12/10/2012
1,765,881,690
6,628,986
$188,419,576,323
4.46%
SEC Edgar Online
10-Q
10-K
00287Y109
US00287Y1091
B92SR70
Common stocks
Large cap
Health Care
Drug Manufacturers—General
USA
USA
12/10/2012
1,765,881,690
6,628,986
$188,419,576,323
4.46%
SEC Edgar Online
10-Q
10-K
00287Y109
US00287Y1091
B92SR70
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
40.82
14.40
4.11
35.30%
10.08%
14.40
4.11
35.30%
10.08%